Joanne F. Chou - Concepedia

Author

Joanne F. Chou

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

Fruscione, Michael, J Chou, J F Chou, J. Chou, J.F. Chou, JOANNE CHOU, Joanne Chou, Joanne F Chou, Joanne F. Chou, Joanne F‐L Chou

456

Publications

8.3K

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Cornell University Molecular Oncology (United States)Kettering University St. Elizabeths Hospital

About

Joanne F. Chou is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	28	1.3K
2	Health Sciences	9	9	226
3	Social Sciences	1	1	34
4	Allergy	1	1	30
5	Biochemistry	1	1	27

Joanne F. Chou

Publications

Citations

H-Index

Page 1

	Year	Citations
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial Ethan Basch, Allison M. Deal, Mark G. Kris, Journal of Clinical Oncology	2015	2.5K
Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation Ekaterina Doubrovina, Banu Oflaz-Sozmen, Susan E. Prockop, Blood	2011	416
Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline <i>BRCA/PALB2</i> Mutation Eileen M. O’Reilly, Jonathan W. Lee, Mark M. Zalupski, Journal of Clinical Oncology	2020	383
First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial Yelena Y. Janjigian, Steven B. Maron, Walid K. Chatila, The Lancet Oncology First-line PembrolizumabEsophageal CancerGastrointestinal OncologyMedicinePathology	2020	347
Phase II Trial of Hepatic Artery Infusional and Systemic Chemotherapy for Patients With Unresectable Hepatic Metastases From Colorectal Cancer Michael I. D’Angelica, Camilo Correa‐Gallego, Philip B. Paty, Annals of Surgery	2014	233
Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection Wungki Park, Jiapeng Chen, Joanne F. Chou, Clinical Cancer Research	2020	214
Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma Andrea Cercek, Thomas Boerner, Benjamin Tan, JAMA Oncology	2019	213
PD-1 Blockade in Advanced Adrenocortical Carcinoma Nitya Raj, Youyun Zheng, Virginia Kelly, Journal of Clinical Oncology	2019	181
Prognosis of Acral Melanoma: A Series of 281 Patients Danielle M. Bello, Joanne F. Chou, Katherine S. Panageas, Annals of Surgical Oncology Acral MelanomaMedicineMelanomaDermatologyOncology	2013	151
<i>KRAS</i> mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases Nancy E. Kemeny, Joanne F. Chou, Marinela Capanu, Cancer	2014	147

Page 1